Latest Atheroma Stories
New data from Phase 1b/2a trial included TSX Exchange Symbol: RVX HAMBURG, Germany and CALGARY, AB, June 22 /PRNewswire-FirstCall/ - Resverlogix Corp.
PLYMOUTH, Mich., June 14 /PRNewswire/ -- Esperion Therapeutics, a privately held biopharmaceutical company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced the establishment of a collaborative research agreement with Cleveland Clinic, one of the world's leading academic medical centers.
NEJM authors: Physicians should consider this when tailoring treatment plans to beat stroke.
ABBOTT PARK, Ill., May 26 /PRNewswire-FirstCall/ -- Data from the CREST (Carotid Revascularization Endarterectomy vs. Stenting Trial) study were published today in The New England Journal of Medicine.
Researchers from Boston University School of Medicine (BUSM) have shown that use of magnetic resonance imaging (MRI) in an animal model can non-invasively identify dangerous plaques.
Finding could lead to the development of new treatments for atherosclerosis.
A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defenseâ€™s T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.
Cholesterol crystals lead to life-threatening inflammation in blood vessel walls.
TSX Exchange Symbol: RVX SAN FRANCISCO and CALGARY, April 9 /PRNewswire-FirstCall/ - Resverlogix Corp.
Two stroke-prevention procedures are safe and equally beneficial for men and women at risk for stroke, but the effectiveness does vary by age.
- A trick or prank.